Skip to content

Nootropic Candidates Inhibit Head-Twitches Induced by Mescaline in Mice

Tsuneyuki Yamamoto, Masuo Ohno, Shin‐ichi Yatsugi, Yasuhiro Fujikawa, Showa Ueki

The Japanese Journal of Pharmacology 1992 DOI: 10.1016/s0021-5198(19)35545-3 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Experimental study Peer reviewed
Population Mice
Interventions Idebenone Minaprine Nebracetam Tetrahydroaminoacridine NIK-247 Physostigmine
Dose Mescaline 100 mg/kg s.c.; Idebenone 32 and 100 mg/kg i.p.; Minaprine 0.32–10 mg/kg p.o.; Nebracetam 100 mg/kg p.o.; Tetrahydroaminoacridine 1 and 10 mg/kg p.o.; NIK-247 10 and 18 mg/kg p.o.; Physostigmine 0.32 mg/kg i.p.
Measures head-twitch response
Topics Mescaline
Keywords Physostigmine Nootropic Pharmacology Cholinesterase Cholinergic Piracetam Head geology Idebenone Acetylcholine Hallucinogen Endocrinology
Citations 1
Key findings Idebenone, minaprine, nebracetam, and cholinesterase inhibitors suppressed mescaline-induced head-twitches in mice, suggesting cholinergic activation may be involved.

Abstract

The effects of various nootropic candidates on mescaline-induced head-twitches were studied in mice. The number of head-twitches induced by mescaline (100 mg/kg, s.c.) was significantly reduced by idebenone (32 and 100 mg/kg, i.p.), minaprine (0.32–10 mg/kg, p.o.) and nebracetam (100 mg/kg, p.o.). Cholinesterase inhibitors such as tetrahydroaminoacridine (1 and 10 mg/kg, p.o.), NIK-247 (10 and 18 mg/kg, p.o.) and physostigmine (0.32 mg/kg, i.p.) also suppressed the head-twitch response to mescaline. These results suggest that the direct or indirect cholinergic-activating effects of these drugs may be involved in inhibiting mescaline-induced head-twitches.

Explore topics